Humana Inc. (NYSE:HUM) Shares Purchased by Quantbot Technologies LP

Quantbot Technologies LP increased its stake in shares of Humana Inc. (NYSE:HUM) by 1.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,121 shares of the insurance provider’s stock after purchasing an additional 453 shares during the quarter. Humana accounts for 0.5% of Quantbot Technologies LP’s holdings, making the stock its 15th largest holding. Quantbot Technologies LP’s holdings in Humana were worth $8,363,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of HUM. Rakuten Securities Inc. acquired a new position in Humana during the 4th quarter worth $25,000. Gradient Investments LLC lifted its holdings in Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after buying an additional 40 shares during the last quarter. Cetera Trust Company N.A purchased a new stake in Humana during the 4th quarter worth about $28,000. Private Wealth Management Group LLC purchased a new stake in Humana during the 4th quarter worth about $32,000. Finally, Carolinas Wealth Consulting LLC lifted its holdings in Humana by 274.1% during the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after buying an additional 74 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Baird R W raised Humana to a “hold” rating in a report on Thursday, May 30th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $360.00 price target on shares of Humana in a report on Wednesday, June 12th. Wells Fargo & Company reduced their target price on Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Robert W. Baird began coverage on Humana in a report on Thursday, May 30th. They issued a “neutral” rating and a $374.00 target price for the company. Finally, Piper Sandler began coverage on Humana in a report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 target price for the company. Fourteen equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $409.55.

Humana Stock Performance

NYSE HUM traded up $2.49 on Friday, hitting $382.22. 1,049,371 shares of the company’s stock were exchanged, compared to its average volume of 1,772,646. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The firm’s 50-day moving average price is $354.15 and its two-hundred day moving average price is $347.04. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The firm has a market cap of $46.06 billion, a price-to-earnings ratio of 23.64, a P/E/G ratio of 2.19 and a beta of 0.51.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $9.38 EPS. On average, research analysts expect that Humana Inc. will post 16.27 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.